Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7504152rdf:typepubmed:Citationlld:pubmed
pubmed-article:7504152lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C0023440lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C0521432lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C0039654lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C1623117lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C0964782lld:lifeskim
pubmed-article:7504152lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:7504152pubmed:issue12lld:pubmed
pubmed-article:7504152pubmed:dateCreated1994-1-6lld:pubmed
pubmed-article:7504152pubmed:abstractTextChanges in c-kit proto-oncogene expression were examined in a human erythroleukemia cell line, HEL, during 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced megakaryocytic differentiation. When HEL cells were treated with 10(-7) M TPA, glycophorin A expression and hemoglobin synthesis were reduced, while the expression of GP IIb/IIIa was induced in association with the morphological changes. Northern blot analysis showed that, during this megakaryocytic differentiation of HEL cells, c-kit mRNA expression persisted even after there was an apparent reduction in c-myc mRNA. This finding supports the idea that the expression of c-kit, a marker of primitive hematopoietic progenitors, may persist along with differentiation toward a megakaryocytic lineage.lld:pubmed
pubmed-article:7504152pubmed:languageenglld:pubmed
pubmed-article:7504152pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:citationSubsetIMlld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7504152pubmed:statusMEDLINElld:pubmed
pubmed-article:7504152pubmed:monthDeclld:pubmed
pubmed-article:7504152pubmed:issn0145-2126lld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:TakahashiKKlld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:BRUCKM AMAlld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:NishikawaMMlld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:OzawaKKlld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:UemuraNNlld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:TaneGGlld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:IkebuchiKKlld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:RottN NNNlld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:Baki?MMlld:pubmed
pubmed-article:7504152pubmed:authorpubmed-author:ZaikeYYlld:pubmed
pubmed-article:7504152pubmed:issnTypePrintlld:pubmed
pubmed-article:7504152pubmed:volume17lld:pubmed
pubmed-article:7504152pubmed:geneSymbolc-kitlld:pubmed
pubmed-article:7504152pubmed:ownerNLMlld:pubmed
pubmed-article:7504152pubmed:authorsCompleteYlld:pubmed
pubmed-article:7504152pubmed:pagination1079-82lld:pubmed
pubmed-article:7504152pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:meshHeadingpubmed-meshheading:7504152-...lld:pubmed
pubmed-article:7504152pubmed:year1993lld:pubmed
pubmed-article:7504152pubmed:articleTitleSustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).lld:pubmed
pubmed-article:7504152pubmed:affiliationDepartment of Hematology-Oncology, University of Tokyo, Japan.lld:pubmed
pubmed-article:7504152pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7504152pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed